APOB and fatty liver disease: LDL-cholesterol, non-HDL-cholesterol, apolipoprotein B, and triglycerides were reduced. Liver weight, hepatic steatosis, plasma alanine aminotransferase activity, and blood glucose were reduced. The dose of 80 mg has the greatest effect on lipid metabolism.